Suven Pharmaceuticals Limited

NSE:SUVENPHAR.NS

1076.9 (INR) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 368.20504.9887,535575.767-4,869.49648.028-4,123.004665.701-5,257.862445.638-2,293.932173.378-1,877.7671.822-876.308121.453-443.624116.953-198.405109.03
Short Term Investments 6,361.607,738.95506,562.69,738.984,224.2798,246.0083,457.30310,515.7244,812.2244,587.8642,120.5543,755.521,805.9381,752.616754.883887.248306.761396.8170.638
Cash and Short Term Investments 6,729.88,211.2678,243.9437,5357,138.3674,869.494,872.3074,123.0044,123.0045,257.8625,257.8622,293.9322,293.9321,877.761,877.76876.308876.336443.624423.714198.405179.668
Net Receivables 001,336.5921,2641,368.98701,109.39301,111.54502,363.72301,639.02401,023.82101,055.43401,171.95800
Inventory 2,154.802,311.9572,5322,714.62903,128.10503,183.07902,834.17302,646.22702,010.80401,974.88101,748.72301,570.982
Other Current Assets 2,791.90758.1350470.2540857.9210807.3260657.5680719.1630619.0790883.022064.334034.439
Total Current Assets 11,676.58,211.26712,631.86311,33111,690.6874,869.4910,110.4584,123.0049,224.9545,257.86211,279.322,293.9327,298.3461,877.765,647.852876.3084,789.645443.6243,916.467198.4053,897.342
Non-Current Assets:
Property, Plant & Equipment, Net 8,927.607,867.767,8277,612.45507,662.24906,948.33705,619.51305,534.105,348.89605,040.97304,556.5303,792.808
Goodwill 2,137.60602.58360300602.58300000000000000
Intangible Assets 577.80619.25717620.2110621.9020623.053022.364024.35025.904026.018027.96026.851
Goodwill and Intangible Assets 2,715.40619.257620620.2110621.9020623.053022.364024.35025.904026.018027.96026.851
Long Term Investments -4,941.401,399.6140-5,323.45101,170.96601,170.96601,170.96603,658.81401,853.93602,557.70202,815.2790-26.191
Tax Assets 73.8044.76106,562.872059.344059.8950203.711052.02601,808.1420755.5030000
Other Non-Current Assets 6,603.7-8,211.267-22.3980134.96-4,869.4932.519-4,123.00432.952-5,257.862-0.001-2,293.93257.582-1,877.7659.921-876.30813.633-443.624411.869-198.405139.353
Total Non-Current Assets 13,379.1-8,211.2679,909.0029,2489,507.047-4,869.499,546.98-4,123.0048,835.203-5,257.8627,016.553-2,293.9329,326.872-1,877.769,096.799-876.3088,393.829-443.6247,811.638-198.4053,932.821
Total Assets 25,055.6022,540.86520,57921,197.734019,657.438018,060.157018,295.873016,625.218014,744.651013,183.474011,728.10507,830.163
Liabilities & Equity:
Current Liabilities:
Account Payables 652.80423.574420425.9390487.7180855.55901,059.0050982.1480829.3130802.9160710.5570535.749
Short Term Debt 880437.6080499.190650.7680707.4030682.240945.4301,067.0580976.9340944.4210827.936
Tax Payables 128.20003.98502.9390130.752036.422012.721000135.807052.53601.096
Deferred Revenue 006.8870149.5750255.720423.5060340.7040292.350278.5450358.7260309.6530159.691
Other Current Liabilities 1,512.40200.888045.0960438.156047.6560287.271057.1750301.0370-109.8010284.1860211.306
Total Current Liabilities 2,381.401,068.9574201,123.78501,587.65802,164.87602,102.9402,289.82402,197.4802,164.58202,003.71501,576.087
Non-Current Liabilities:
Long Term Debt 306.60212.35734517.356052.640207.3930289.0330361.340363.2990559.8440917.64400
Deferred Revenue Non-Current 000000128.5930296.0780373.3490417.2540000083.14600
Deferred Tax Liabilities Non-Current 859.30647.9120619.0610582.3460563.240543.1510332.4840309.3290276.3720275.9720291.717
Other Non-Current Liabilities 1,224.1-20,506.635752.915083.4940665.297094.0920632.096066.460375.789083.14600.001059.453
Total Non-Current Liabilities 2,390-20,506.635965.272345719.9110717.9370864.7250921.1290760.2840739.0880919.36201,276.7630351.17
Total Liabilities 4,771.4-20,506.6352,034.2297651,843.69602,305.59503,029.60103,024.06903,050.10802,936.56803,083.94403,280.47801,927.257
Equity:
Preferred Stock 000000000000000000000
Common Stock 254.60254.56519,814254.5650254.5650254.5650254.5650254.5650254.5650254.5650127.2820127.282
Retained Earnings 0017,651.1800014,651.60600012,727.0860009,364.9260006,154.44303,909.835
Accumulated Other Comprehensive Income/Loss 020,506.6351,505.152019,099.47317,351.8431,349.93415,030.55614,775.99115,271.8041,194.41413,575.1113,320.54511,808.0831,350.30310,099.539,844.9658,447.627150.1145,902.9060
Other Total Stockholders Equity 19,528.801,095.7380001,095.7380001,095.7380001,095.7380001,223.02101,865.788
Total Shareholders Equity 19,783.420,506.63520,506.63519,81419,354.03817,351.84317,351.84315,030.55615,030.55615,271.80415,271.80313,575.1113,575.1111,808.08311,808.08310,099.5310,099.538,447.6278,447.6275,902.9065,902.905
Total Equity 20,284.220,506.63520,506.63519,81419,354.03817,351.84317,351.84315,030.55615,030.55615,271.80415,271.80313,575.1113,575.1111,808.08311,808.08310,099.5310,099.538,447.6278,447.6275,902.9065,902.905
Total Liabilities & Shareholders Equity 25,055.6022,540.86520,57921,197.73417,351.84319,657.43815,030.55618,060.15715,271.80418,295.87213,575.1116,625.21811,808.08314,744.65110,099.5313,183.4748,447.62711,728.1055,902.9067,830.162